Intraoperative Hypotension Management with Vasopressors
Treatment Algorithm Based on Underlying Cause
- The Perioperative Quality Initiative (POQI) consensus provides a strong recommendation (high-quality evidence) to base hypotension treatment on the presumed underlying physiological cause, with phenylephrine or norepinephrine as first-line vasopressors for vasodilation-induced hypotension 1, 2, 3
- For patients with vasodilation and bradycardia, ephedrine may be considered, but avoid phenylephrine alone as it may cause reflex bradycardia and decrease cardiac output 1, 4
- For patients with low cardiac output or myocardial dysfunction, epinephrine or dobutamine may be used to provide positive inotropic support, and norepinephrine may be preferred over phenylephrine when cardiac output maintenance is critical 1, 4, 5
Blood Pressure Targets
- The American Heart Association recommends maintaining a mean arterial pressure (MAP) ≥60-65 mmHg or systolic blood pressure (SBP) >90 mmHg to prevent organ injury, with higher targets (≥80 mmHg) considered for patients with increased compartment pressures 6, 1, 5, 9
- For patients with baseline hypertension, target SBP >70% of preoperative baseline, and avoid drops >30% below baseline, which is associated with end-organ injury 6, 7
Critical Pitfalls to Avoid
- Do not delay vasopressor treatment while waiting for fluid resuscitation if MAP <60-65 mmHg or SBP <90 mmHg, as prolonged hypotension (>15 minutes) causes organ injury 6, 7, 8
- Avoid treating hypertension aggressively during propofol anesthesia, as SBP 120-200 mmHg is not associated with organ injury, while subsequent hypotension from overzealous treatment causes harm 1, 2, 3